1. Home
  2. CLNE vs ADCT Comparison

CLNE vs ADCT Comparison

Compare CLNE & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Energy Fuels Corp.

CLNE

Clean Energy Fuels Corp.

HOLD

Current Price

$2.15

Market Cap

478.4M

Sector

Utilities

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$4.01

Market Cap

484.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLNE
ADCT
Founded
2001
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.4M
484.4M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
CLNE
ADCT
Price
$2.15
$4.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$3.49
$7.50
AVG Volume (30 Days)
996.5K
883.7K
Earning Date
05-07-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.86
EPS
N/A
N/A
Revenue
$341,599,000.00
$81,357,000.00
Revenue This Year
$5.99
$1.15
Revenue Next Year
$17.00
$86.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.85
52 Week Low
$1.30
$1.05
52 Week High
$3.11
$4.98

Technical Indicators

Market Signals
Indicator
CLNE
ADCT
Relative Strength Index (RSI) 37.85 45.91
Support Level $2.11 $3.79
Resistance Level $2.26 $4.63
Average True Range (ATR) 0.10 0.29
MACD -0.02 -0.05
Stochastic Oscillator 12.31 5.96

Price Performance

Historical Comparison
CLNE
ADCT

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas and liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The firm operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. It also builds, operates, and maintains natural gas fueling stations for customers.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: